Link to Pubmed | Location | DNA nomenclature | RNA nomenclature | Protein nomenclature | Type of variant DNA | Type of variant RNA | Type of variant Protein | MAF | RS number | Biochemical evidence of pathogenicity | Splicing and translation prediction | Biochemical evidence of CRIM status | Prediction of CRIM status | Number of patients | Id | Predicted severity | Phenotype with null allele | CRIM status | Missense prediction (Mutation Taster) | Missense prediction (SIFT) | Missense prediction (Align GVGD) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PubMed | exon 16 | c.2238G>C | r.(2238g>c) | p.(Trp746Cys) | Substitution | Substitution | Substitution (missense) | MAF is less than 1% | rs1800312 | gives 29,4% residual activity in expression study | strengthens a cryptic splice donor site | unknown | 777 | Potentially mild | Childhood or adult | Unknown | Disease causing (p-value: 1) | Deleterious (score: 0) | Class C0 (GV: 268.54 - GD: 1.62) | ||
Link to patients |
Allele 1 DNA |
Allele 2 Location |
Allele 2 DNA |
Allele 2 Phenotype with a null allele |
Phenotype of patient |
Age of Onset |
Gender |
Age at analysis |
Cardiomyopathy |
Liver/ Spleen |
Ventilatory support |
Respiratory problems |
Wheelchair dependency |
Mobility problems |
(Kypho) Scoliosis |
Ptosis |
Scapular winging |
Cerebral vessels anomalies |
No of patients reported |
Country/Region | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PubMed | c.2238G>C | exon 2 | c.241C>T | Unknown (disease-associated) | Childhood (2)/ Adult (1) | 16 years/12 years/27 years | M/ F/ F | 24y/31y/29y | +/-/+ | +/-/+ | unknown/unknown/+ | 3 | China | ||||||||
PubMed | c.2238G>C | exon 2 | c.444C>G | Unknown (disease-associated) | Adult | 23 years | F | 28 years | - | + | + | + | + | 1 | Malaysian Chinese | ||||||
PubMed | c.2238G>C | exon 5 | c.871C>T | Unknown (disease-associated) | Childhood | 12 years | M | 12 years | - | 1 | China | ||||||||||
PubMed | c.2238G>C | exon 8 | c.1320_1322del | Unknown (disease-associated) | Childhood | 15 years | F | 25 years | + | + | 1 | China | |||||||||
PubMed | c.2238G>C | exon 9 | c.1356del | Unknown (disease-associated) | Adult | 21 years | F | 23 years | + | + | 1 | China | |||||||||
PubMed | c.2238G>C | exon 9 | c.1396del | Classic infantile | Adult | 24 years/23 years | F/ F | 30 years/28 years | -/- | 2 | China | ||||||||||
PubMed | c.2238G>C | intron 10 | c.1551+3_1551+6del | Unknown (disease-associated) | Adult | 23 years | F | 23 years | + | + | 1 | China | |||||||||
PubMed | c.2238G>C | exon 14 | c.1935C>A | Classic infantile | Childhood | unknown (2) | unknown (2) | 2 | Taiwan | ||||||||||||
PubMed | c.2238G>C | exon 14 | c.1935C>A/ Asian pseudodeficiency allele | Classic infantile | Childhood | unknown | M | NBS | - | 1 | Taiwan | ||||||||||
PubMed | c.2238G>C | exon 14 | c.1935C>A | Classic infantile | Childhood (1)/ Adult (1) | 6 years/23 years | M/ F | 14 years/32 years | -/+ | +/+ | 2 | China | |||||||||
PubMed | c.2238G>C | exon 16 | c.2238G>C | Childhood or Adult | Childhood | unknown | unknown | 1 | Taiwan | ||||||||||||
PubMed | c.2238G>C | exon 19 | c.2662G>T/ Asian pseudodeficiency allele | Classic infantile | Childhood | 13-30 months | M | NBS | - | 1 | Taiwan | ||||||||||
PubMed | c.2238G>C | exon 16 | c.2238G>C | Childhood or Adult | Childhood | 17 years | M | 17 years | - | 1 | China | ||||||||||
PubMed | c.2238G>C | second mutation is not reported | Childhood | 10 years | F | 15 years | - | 1 | China | ||||||||||||
PubMed | c.2238G>C | exon 17 | c.2431del | Unknown (disease-associated) | Adult | 25 years | F | 35 years | + | + | 1 | China | |||||||||
PubMed | c.2238G>C | exon 19 | c.2662G>T | Classic infantile | Childhood | 3 years | F | 17 years | - | 1 | China | ||||||||||
PubMed | c.2238G>C | exon 13 | c.1822C>T | Classic infantile | Adult | 41 years | M | 41 years | - | + | + | 1 | South Korea | ||||||||
PubMed | c.2238G>C | exon 16 | c.2235dup | Classic infantile | Childhood | 1 years | M | 18 years | 1 | China | |||||||||||
PubMed | c.2238G>C | exon 14 | c.1935C>A | Classic infantile | Adult | 26/21/32/34 years | F/M/F/F | 29/33/33/36 years | +/+/+/+ | -/-/-/+ | 4 | Hong Kong | |||||||||
PubMed | c.2238G>C | exon 8 | c.1309C>T | Childhood | Childhood | 16 years | M | 26 years | - | - | 1 | Hong Kong | |||||||||
PubMed | c.2238G>C | second mutation is not reported | Adult | >18 | 1 | Belgium | |||||||||||||||
PubMed | c.2238G>C | Asian pseudodeficiency allele (homozygous) | NBS | NBS | 1 | Japan | |||||||||||||||
PubMed | c.2238G>C | exon 17 | c.2297A>C | Classic infantile | Adult | 22 years | M | 1 | China | ||||||||||||
PubMed | c.2238G>C | exon 19 | c.2662G>T | Classic infantile | Adult | 21 years | F | 1 | China | ||||||||||||
PubMed | c.2238G>C | exon 7 | c.1156C>T | Unknown (disease-associated) | Childhood | 5 years | F | 17 y, 5 m | - | + (hepatomegaly) | - | - | Limb girdle weakness | + | 1 | Korea | |||||
PubMed | c.2238G>C | exon 12 | c.1655T>C | Classic infantile | Childhood | 9 years | M | 11 y | + | + (BiPAP) | + | + (assistive device) | + | 1 | Caucasian | ||||||
PubMed | c.2238G>C | exon 15 | c.2105G>A | Classic infantile | Adult | 26 years | F | 1 | China | ||||||||||||
PubMed | c.2238G>C | exon 16 | c.2237G>A | Classic infantile | Childhood | 1 years | M | 1 | China | ||||||||||||
PubMed | c.2238G>C | exon 4 | c.837G>C | Unknown (disease-associated) | Childhood | 14 years | M | 1 | China | ||||||||||||
The Pompe disease GAA variant database represents an effort to collect all known variants in the GAA gene and is maintained and provide by the Pompe center, Erasmus MC. We kindly ask you to reference one of the following articles if you use this database for research purposes: de Faria, DOS, in 't Groen, SLM, Bergsma, AJ, et al. Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease-associated variants, common sequence variants, and results from newborn screening. Niño, MY, in 't Groen, SLM, Hoogeveen-Westerveld, M, et al. Extension of the Pompe mutation database by linking disease‐associated variants to clinical severity. Human Mutation. 2019; 40: 1954–1967. https://doi.org/10.1002/humu.23854 |
www.pompecenter.nl |
|